Increasing the Usefulness of PROs in Oncology Research
Signant Health's Dr. Everhart and Professor Meyer discuss innovations in patient-reported outcomes for cancer research, advancing clinical trial...
Signant Health's Dr. Everhart and Professor Meyer discuss innovations in patient-reported outcomes for cancer research, advancing clinical trial...
Learn how addressing caregiver challenges can improve patient retention, medication adherence, and trial outcomes in clinical research.
In this webinar we explore the benefits of incorporating PROs in early phase oncology trials to inform optimal dose determination.